Seema Dawood/LinkedIn
Jul 29, 2026, 17:41
Seema Dawood: Difference Between CBC Smear Staining and Cell Counts Staining
Seema Dawood, Medical Laboratory Technologist at The Aga Khan University Hospital, shared a post on LinkedIn:
“Difference Between CBC Smear Staining and Cell Counts (Body Fluid ) Staining
CBC (Complete Blood Count) Smear Staining
- Uses Romanowsky type stains (e.g., Wright, Giemsa, Leishman).
- Contains methanol as a fixative and produces a metallic sheen when properly stained.
- Purpose: to clearly visualize cell morphology, including red blood cells (RBCs), white blood cells (WBCs), and platelets.
- The metallic sheen indicates good staining quality and proper fixation.
Cell Count Smear Staining (e.g., CSF, body fluid, or urine sediment)
- Uses buffered solution (such as phosphate buffer) or diluted stain.
- Buffer is added until the preparation appears almost clear, providing a clean background for better visualization of cells.
- Purpose: to count and identify cell types, not to examine detailed morphology.
- Does not produce Metallic Sheen; staining is lighter and more transparent.
Summary
- CBC smear: Metallic Sheen, emphasizes morphology.
- Cell count smear: clear/transparent, emphasizes cell number and identification, not morphology.”

Other posts featuring Seema Dawood on Hemostasis Today.
-
Jul 29, 2026, 16:30Mostafa Faisal: Impact of DNMT3A and TET2 Mutations on Clotting and Bleeding in PV and ET
-
Jul 29, 2026, 16:01Gerardo Moscatelli: The Spike Protein Cascade – From Endothelial Binding to Vascular Collapse
-
Jul 29, 2026, 15:42Julie Cardoso: FDA Clears the First AI-Guided Ultrasound Software for Suspected DVT
-
Jul 29, 2026, 15:26Ahmad Alkhammash: Completing an Advanced Fellowship in Adult Thrombosis Medicine
-
Jul 29, 2026, 15:13Yara Mahmoud: The Molecular Basis in Hematology
-
Jul 29, 2026, 15:11Louisa Jorm: A New Era of Dynamic Cardiovascular Risk Assessment
-
Jul 29, 2026, 15:04Filippo Consonni: Treatment Strategies for Hematologic Immune Dysregulation in Inborn Errors of Immunity
-
Jul 29, 2026, 14:53Samer Alsaid: Warfarin Outcomes Reassessed Through COMBINE AF
-
Jul 29, 2026, 14:46François Saller: TFPI-Targeting VHHs for Haemophilia and Rare Bleeding Disorders